Clark Eliana
SEC insider (Form 3/4/5 filer). CIK 0001914448. EVP, Chief Technical Officer at Intellia Therapeutics, Inc. (NTLA). 8 reported Form 4/5 transactions since Sep 2024; latest on Mar 2, 2026. Located in CAMBRIDGE, MA.
Companies Clark Eliana has filed insider reports for
- Intellia Therapeutics, Inc. (NTLA): Officer, EVP, Chief Technical Officer
Clark Eliana
CIK: 0001914448
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Intellia Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Mar 2, 2026NTLA
Intellia Therapeutics, Inc.
SaleDirect607 shares at avg. $13.78$8K - Mar 1, 2026NTLA
Intellia Therapeutics, Inc.
AwardDirect7.4K shares- - Jan 5, 2026NTLA
Intellia Therapeutics, Inc.
SaleDirect9.5K shares at avg. $9.21$88K - Jul 1, 2025NTLA
Intellia Therapeutics, Inc.
SaleDirect1K shares at avg. $9.82$10K - Mar 4, 2025NTLA
Intellia Therapeutics, Inc.
SaleDirect679 shares at avg. $8.99$6K - Mar 1, 2025NTLA
Intellia Therapeutics, Inc.
AwardDirect32K shares- - Jan 3, 2025NTLA
Intellia Therapeutics, Inc.
SaleDirect7.4K shares at avg. $12.18$90K - Jan 2, 2025NTLA
Intellia Therapeutics, Inc.
SaleDirect556 shares at avg. $12.03$7K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 2, 2026 | NTLA Intellia Therapeutics, Inc. | Sale | 607 | $13.78 | $8,364 | Direct |
| Mar 1, 2026 | NTLA Intellia Therapeutics, Inc. | Award | 7,353 | - | $0 | Direct |
| Jan 5, 2026 | NTLA Intellia Therapeutics, Inc. | Sale | 9,515 | $9.21 | $87,633 | Direct |
| Jul 1, 2025 | NTLA Intellia Therapeutics, Inc. | Sale | 1,022 | $9.82 | $10,036 | Direct |
| Mar 4, 2025 | NTLA Intellia Therapeutics, Inc. | Sale | 679 | $8.99 | $6,104 | Direct |
| Mar 1, 2025 | NTLA Intellia Therapeutics, Inc. | Award | 32,000 | - | - | Direct |
| Jan 3, 2025 | NTLA Intellia Therapeutics, Inc. | Sale | 7,422 | $12.18 | $90,400 | Direct |
| Jan 2, 2025 | NTLA Intellia Therapeutics, Inc. | Sale | 556 | $12.03 | $6,689 | Direct |
1-8 of 8 transactions